Paolo Calabrò

ORCID: 0000-0002-5018-830X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Lipoproteins and Cardiovascular Health
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Cardiomyopathy and Myosin Studies
  • Cardiac Valve Diseases and Treatments
  • Diabetes Treatment and Management
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiac Arrhythmias and Treatments
  • Vascular Procedures and Complications
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Effects of Exercise
  • Cancer, Lipids, and Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiac Structural Anomalies and Repair
  • Pharmaceutical Economics and Policy
  • Congenital Heart Disease Studies
  • Cardiac pacing and defibrillation studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Diabetes, Cardiovascular Risks, and Lipoproteins

University of Campania "Luigi Vanvitelli"
2016-2025

Ospedale Sant'Anna
2018-2025

Ospedale Monaldi
2011-2025

I.R.C.C.S. Oasi Maria SS
2018-2024

University of Naples Federico II
2010-2024

Sorbonne Université
2024

Assistance Publique – Hôpitaux de Paris
2024

Ospedale Maggiore
2015-2024

Magna Graecia University
2024

University of Catania
2024

Abstract Aims To evaluate the impact of COVID-19 pandemic on patient admissions to Italian cardiac care units (CCUs). Methods and Results We conducted a multicentre, observational, nationwide survey collect data for acute myocardial infarction (AMI) at CCUs throughout 1 week period during outbreak, compared with equivalent in 2019. observed 48.4% reduction AMI 2019 (P < 0.001). The was significant both ST-segment elevation [STEMI; 26.5%, 95% confidence interval (CI) 21.7–32.3; P =...

10.1093/eurheartj/ehaa409 article EN other-oa European Heart Journal 2020-04-29

Background— Serum C-reactive protein (CRP) levels are good predictors of the development cardiovascular events in apparently healthy men and women. CRP has been believed to be produced exclusively by hepatocytes during acute-phase response. Several lines evidence have suggested that atherosclerotic arteries can also produce CRP. However, cell types locally arterial wall not clearly identified. Methods Results— Human coronary artery smooth muscle cells (HCASMCs) human umbilical vein...

10.1161/01.cir.0000096055.62724.c5 article EN Circulation 2003-10-07

Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part percutaneous coronary intervention (PCI) in patients with an acute syndrome.We randomly assigned 7213 syndrome for whom PCI was anticipated to receive either or unfractionated heparin. Patients group were subsequently not a post-PCI infusion. Primary outcomes comparison between heparin occurrence major adverse cardiovascular events (a composite death, myocardial infarction, stroke) net clinical...

10.1056/nejmoa1507854 article EN New England Journal of Medicine 2015-09-01
Marco Valgimigli Enrico Frigoli Sergio Leonardi Pascal Vranckx Martina Rothenbühler and 95 more Matteo Tebaldi Ferdinando Varbella Paolo Calabrò Stefano Garducci Paolo Rubartelli Carlo Briguori Giuseppe Andò Maurizio Ferrario Ugo Limbruno Roberto Garbo Paolo Sganzerla Filippo Russo Marco Stefano Nazzaro Alessandro Lupi Bernardo Cortese Arturo Ausiello Salvatore Ierna Giovanni Esposito Giuseppe Ferrante Andrea Santarelli Gennaro Sardella Nicoletta De Cesare Paolo Tosi Arnoud W.J. van ’t Hof Elmir Ömerovic Salvatore Brugaletta Stephan Windecker Dik Heg Peter Jüni Gianluca Campo Lucia Uguccioni Corrado Tamburino Patrizia Presbitero Dennis Zavalloni-Parenti Fabio Ferrari Roberto Ceravolo Fabio Tarantino Giampaolo Pasquetto Gavino Casu Stefano Mameli Maria Letizia Stochino Pietro Mazzarotto Alberto Cremonesi Francesco Saia Giovanni Saccone Fabio Abate Andrea Picchi Roberto Violini Salvatore Colangelo Giacomo Boccuzzi Vincenzo Guiducci Carlo Vigna Antonio Zingarelli Andrea Gagnor Tiziana Zaro Simone Tresoldi Pietro Vandoni Marco Contarini Armando Liso Antonio Dellavalle Salvatore Curello Fabio Mangiacapra Rosario Evola Cataldo Palmieri Camillo Falcone Francesco Liïstro Manuela Creaco Antonio Colombo Alaide Chieffo Andrea Perkan Stefano De Servi Dionigi Fischetti Stefano Rigattieri Alessandro Sciahbasi Edoardo Pucci Enrico Romagnoli Claudio Moretti Luciano Moretti Raffaele De Caterina Massimo Caputo Marco Zimmarino Ezio Bramucci Emilio Di Lorenzo Maurizio Turturo Roberto Bonmassari Carlo Penzo Bruno Loi Ciro Mauro Anna Sonia Petronio Gabriele Gabrielli Antonio Micari Flavia Belloni Francesco Amico Marco Comeglio Claudio Fresco

10.1016/s0140-6736(18)31714-8 article EN The Lancet 2018-08-25

Abstract Background The inflammatory response occurring in acute myocardial infarction (AMI) has been proposed as a potential pharmacological target. Sodium-glucose co-transporter 2 inhibitors (SGLT2-I) currently receive intense clinical interest patients with and without diabetes mellitus (DM) for their pleiotropic beneficial effects. We tested the hypothesis that SGLT2-I have anti-inflammatory effects along glucose-lowering properties. Therefore, we investigated link between stress...

10.1186/s12933-022-01506-8 article EN cc-by Cardiovascular Diabetology 2022-05-15
Tycho R. Tromp Merel L. Hartgers G. Kees Hovingh Antonio J. Vallejo‐Vaz Kausik K. Ray and 95 more Handrean Soran Tomáš Freiberger Stefano Bertolini Mariko Harada‐Shiba Dirk Blom Frederick J. Raal Marina Cuchel Tycho R. Tromp Merel L. Hartgers G. Kees Hovingh Antonio J. Vallejo‐Vaz Kausik K. Ray Handrean Soran Tomáš Freiberger Stefano Bertolini Mariko Harada‐Shiba Jing Pang Gerald F. Watts Susanne Greber‐Platzer Martin Mäser Thomas M. Stulnig Christoph Ebenbichler Khalid Bin Thani David Cassiman Olivier Descamps Daisy Rymen Peter Witters Raúl D. Santos Liam R. Brunham Gordon A. Francis Jacques Genest Robert A. Hegele Brooke A. Kennedy Isabelle L. Ruel Mark Sherman Long Jiang Luya Wang Željko Reiner V. Bláha R Češka Jana Dvořáková Lubomir Dlouhy Pavel Horák Vladimír Soška Lukáš Tichý Robin Urbánek H Vaverková Michal Vráblík Stanislav Zemek Lukáš Zlatohlávek Sameh Emil Tarek Naguib Ashraf Reda Sophie Béliard Éric Bruckert Antonio Gallo Moses Elisaf Genovefa Kolovou Hofit Cohen Ronen Durst Eldad J. Dann Avishay Elis Osama Hussein Eran Leitersdorf Daniel Schurr Nitika Setia Ishwar C. Verma Mohammed Alareedh Mutaz Al-Khnifsawi Ali Fawzi Abdalsahib Sabah H. Rhadi Foaad Shaghee Marcello Arca Maurizio Averna Andrea Bartuli Marco Bucci Paola Sabrina Buonuomo Paolo Calabrò S. Calandra Manuela Casula Alberico L. Catapano Angelo B. Cefalù Arrigo F.G. Cicero Sergio D’Addato Laura D’Erasmo Alessia Di Costanzo Tommaso Fasano Marta Gazzotti Antonina Giammanco Gabriella Iannuzzo Anastasia Ibba Emanuele Alberto Negri Andrea Pasta Chiara Pavanello Livia Pisciotta

10.1016/s0140-6736(21)02001-8 article EN The Lancet 2022-01-28

Abstract Background Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to reduction major adverse cardiovascular events (MACEs) in type diabetes mellitus (T2DM) patients with ischemic heart disease (IHD). T2DM multivessel non-obstructive coronary stenosis (Mv-NOCS) have over-inflammation over-lipids’ accumulation. This reduce fibrous cap thickness (FCT), favoring rupture MACEs. Despite...

10.1186/s12933-023-01814-7 article EN cc-by Cardiovascular Diabetology 2023-04-01

No study evaluated the incidence of intra-stent restenosis (ISR)-related events in patients with type 2 diabetes (T2DM) and acute myocardial infarction (AMI) treated or not sodium/glucose cotransporter inhibitors (SGLT2i).We recruited 377 T2DM AMI undergoing percutaneous coronary intervention (PCI). Among them, 177 were SGLT2 before PCI. The primary outcome was major adverse cardiovascular (MACE) defined as cardiac death, re-infarction, heart failure related to ISR. In without ISR, minimal...

10.1186/s12916-023-02781-2 article EN cc-by BMC Medicine 2023-02-24

Abstract Background Few studies explored the effect of combination glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on incidence cardiovascular events in patients with type 2 diabetes (T2D) acute myocardial infarction (AMI). Methods We recruited T2D AMI undergoing percutaneous coronary intervention, treated either SGLT-2i or GLP-1RA for at least 3 months before hospitalization. Subjects HbA1c < 7% admission were considered good...

10.1186/s12933-023-02118-6 article EN cc-by Cardiovascular Diabetology 2024-01-06

Resistin, a novel adipokine, is elevated in patients with type 2 diabetes and may play role the vascular complications of this disorder. One recent study has shown that resistin proinflammatory effect on endothelial cells. However, there no information whether could also affect smooth muscle cells (SMCs). Thus, purpose was to assess induce SMC proliferation mechanisms whereby signals SMCs.Human aortic (HASMCs) were stimulated increasing concentrations for 48 hours. Cell induced by...

10.1161/01.cir.0000147825.97879.e7 article EN Circulation 2004-11-16

Accurate echocardiographic parameters to predict maintenance of sinus rhythm in patients with atrial fibrillation (AF) are poorly defined. This study was conducted assess the myocardial properties during AF through velocity, strain rate, and compare their prognostic value maintaining lone standard transthoracic (TTE) transesophageal echocardiography (TEE).Sixty-five consecutive for < or =3 months underwent TTE, TEE, velocity rate imaging examinations before successful external cardioversion....

10.1161/circulationaha.104.463125 article EN Circulation 2005-07-09

Context: Obesity and iron deficiency are two of the most common nutritional disorders worldwide. Several studies found higher rates in obese than normal-weight children. Hepcidin represents main inhibitor intestinal absorption, its expression is increased adipose tissue patients. Leptin able, vitro, to raise hepcidin expression. Objectives: Aims this work were 1) assess association between poor status obesity, 2) investigate whether homeostasis children may be modulated by serum variations,...

10.1210/jc.2009-1361 article EN The Journal of Clinical Endocrinology & Metabolism 2009-12-01

Relationship between obesity and cardiovascular (CV) disease depends not only on the amount of body fat, but also its distribution. For example, individuals with increased fat accumulation in abdominal region have atherogenic lipid profiles are at CV risk. The loss elasticity medium large arteries is an early manifestation atherosclerosis. aim this study was to evaluate whether echocardiographic epicardial adipose tissue, index cardiac adiposity, related carotid stiffness intima-media...

10.1093/ejechocard/jep002 article EN European Journal of Echocardiography 2009-02-10
Giuseppe Andò Bernardo Cortese Filippo Russo Martina Rothenbühler Enrico Frigoli and 95 more Giuseppe Gargiulo Carlo Briguori Pascal Vranckx Sergio Leonardi Vincenzo Guiducci Flavia Belloni Fabio Ferrari José M. de la Torre Hernández Salvatore Curello Francesco Liïstro Andrea Perkan Stefano De Servi Gavino Casu Antonio Dellavalle Dionigi Fischetti Antonio Micari Bruno Loi Fabio Mangiacapra Nunzio Russo Fabio Tarantino Francesco Saia Dik Heg Stephan Windecker Peter Jüni Marco Valgimigli Maria Salomone Enrico Frigoli Pierpaolo Occhilupo Veronica Lodolini Monia Monti Maria Grazia Mazzone Erika Delos Maria Teresa Caruso Maggie Testa Nestor Ciociano Maurizio Lazzero Davide Gazzotti Lorenzo Cagliari Leila Shahmohammadi Martina Caiazza Vittorio Virga Elena Guerra E Michalska S Castellini Vincenzo Serino Gabriella Visconti Gianluca Pendenza Monica Portolan Marco Anzini Elisa Silvetti Tiziana Coco Francesco Costa Sara Ariotti Linda Valli Marianna Adamo Marcello Marino Pascal Vranckx Sergio Leonardi Pierluigi Tricoci Peter Jüni Martina Rothenbühler Dik Heg Marco Valgimigli Andrea Gagnor Paolo Calabrò Paolo Rubartelli Stefano Garducci Giuseppe Andò Andrea Santarelli Mario Galli Roberto Garbo Ezio Bramucci Salvatore Ierna Carlo Briguori Bernardo Cortese Ugo Limbruno Roberto Violini Patrizia Presbitero Nicoletta De Cesare Paolo Sganzerla Arturo Ausiello Paolo Tosi Gennaro Sardella Manel Sabaté Salvatore Brugaletta Giovanni Saccone Pietro Vandoni Antonio Zingarelli Armando Liso Stefano Rigattieri Emilio Di Lorenzo Carlo Vigna Cataldo Palmieri Camillo Falcone Raffaele De Caterina

10.1016/j.jacc.2017.02.070 article EN publisher-specific-oa Journal of the American College of Cardiology 2017-05-01

OBJECTIVE To evaluate the effect of metformin therapy on coronary endothelial function and major adverse cardiac events (MACE) in patients with prediabetes stable angina nonobstructive stenosis (NOCS). RESEARCH DESIGN AND METHODS Metformin may be needed to reduce heart disease risk prediabetes. A total 258 propensity score–matched (PSM) undergoing angiography were enrolled study. Data from 86 PSM subjects normoglycemia (NG), (pre-DM), treated (pre-DM metformin) analyzed. During angiography,...

10.2337/dc18-2356 article EN Diabetes Care 2019-02-22
Coming Soon ...